Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herombopag for Chemotherapy and Immunotherapy-Induced Thrombocytopenia in NSCLC
NCT05252091Phase 2Unknown
- Sponsor
- Henan Cancer Hospital
- Start
- Feb 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hetrombopag in Thrombocytopenia, sponsored by Henan Cancer Hospital. Status: unknown.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT05252091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05252091.